<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39360640</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>Unravel the distinct effects of adiposity at different life stages on COVID-19 susceptibility and severity: A life-course Mendelian randomization study.</ArticleTitle><Pagination><StartPage>e29943</StartPage><MedlinePgn>e29943</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.29943</ELocationID><Abstract><AbstractText>Childhood obesity is widely recognized as a risk factor for numerous health conditions, particularly cardiovascular disease. However, it remains unclear whether childhood adiposity directly affects the risk of COVID-19 in later life. We aimed to investigate the causal effects of early life adiposity on COVID-19 susceptibility and severity. We used genetic instruments from large-scale genome-wide association studies to examine the relationships between birth weight, childhood and adulthood adiposity indicators (including body mass index [BMI], obesity, and body size), and COVID-19 outcomes. Univariable and multivariable Mendelian randomization (MR) analyses were used to obtain the causal estimates. Univariable MR analyses found that childhood BMI and obesity were positively associated with COVID-19 risk and severity in adulthood, however, the significant associations were attenuated to null after further adjusting for adulthood adiposity indicators in multivariable MR analyses. In contrast, our analysis revealed strong evidence of a genetically predicted effect of childhood obesity on COVID-19 hospitalization (OR 1.08, 95% CI: 1.01-1.15, p = 2.12E-2), which remained robust even after adjusting for adulthood obesity and potential lifestyle confounders. Our results highlight the importance of promoting healthy weight management throughout life to reduce the risk of COVID-19.</AbstractText><CopyrightInformation>© 2024 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Pei</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9976-7655</Identifier><AffiliationInfo><Affiliation>Center for Non-communicable Disease Management, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Chi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of AIDS/STD Control and Prevention, Shijingshan District Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jinyi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Public Health, Wuhan Fourth Hospital, Wuhan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of public health, Fudan university, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Jiayuan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Rare Diseases, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>82204061</GrantID><Agency>National Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>BCHYIP3-1-014-01-33</GrantID><Agency>BCH Young Investigator Program</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057182" MajorTopicYN="Y">Mendelian Randomization Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050154" MajorTopicYN="Y">Adiposity</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="Y">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063766" MajorTopicYN="N">Pediatric Obesity</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004198" MajorTopicYN="N">Disease Susceptibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001724" MajorTopicYN="N">Birth Weight</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID‐19</Keyword><Keyword MajorTopicYN="N">Mendelian randomization</Keyword><Keyword MajorTopicYN="N">causal effect</Keyword><Keyword MajorTopicYN="N">childhood adiposity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>16</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>7</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39360640</ArticleId><ArticleId IdType="doi">10.1002/jmv.29943</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Micah AE, Cogswell IE, Cunningham B, et al. Tracking development assistance for health and for COVID‐19: a review of development assistance, government, out‐of‐pocket, and other private spending on health for 204 countries and territories, 1990‐2050. Lancet. 2021;398(10308):1317‐1343.</Citation></Reference><Reference><Citation>Fajar JK, Ilmawan M, Mamada S, et al. Global prevalence of persistent neuromuscular symptoms and the possible pathomechanisms in COVID‐19 recovered individuals: A systematic review and meta‐analysis. Narra J. 2021;1(3):e48.</Citation></Reference><Reference><Citation>NCD Risk Factor Collaboration (NCD‐RisC). Worldwide trends in body‐mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population‐based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627‐2642.</Citation></Reference><Reference><Citation>Tadayon Najafabadi B, Rayner DG, Shokraee K, et al Obesity as an independent risk factor for COVID‐19 severity and mortality. Cochrane Database Syst Rev. 2023;5(5):CD015201.</Citation></Reference><Reference><Citation>Richardson TG, Sanderson E, Elsworth B, Tilling K, Davey Smith G. Use of genetic variation to separate the effects of early and later life adiposity on disease risk: mendelian randomisation study. BMJ. 2020;369:m1203. doi:10.1136/bmj.m1203</Citation></Reference><Reference><Citation>Richardson TG, Mykkänen J, Pahkala K, et al. Evaluating the direct effects of childhood adiposity on adult systemic metabolism: a multivariable Mendelian randomization analysis. Int J Epidemiol. 2021;50(5):1580‐1592.</Citation></Reference><Reference><Citation>Skrivankova VW, Richmond RC, Woolf BAR, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization. JAMA. 2021;326(16):1614.</Citation></Reference><Reference><Citation>Carter AR, Sanderson E, Hammerton G, et al. Mendelian randomisation for mediation analysis: current methods and challenges for implementation. Eur J Epidemiol. 2021;36(5):465‐478.</Citation></Reference><Reference><Citation>Vogelezang S, Bradfield JP, Ahluwalia TS, et al. Novel loci for childhood body mass index and shared heritability with adult cardiometabolic traits. PLoS Genet. 2020;16(10):e1008718.</Citation></Reference><Reference><Citation>Warrington NM, Beaumont RN, Horikoshi M, et al Maternal and fetal genetic effects on birth weight and their relevance to cardio‐metabolic risk factors. Nature Genet. 2019;51(5):804‐814.</Citation></Reference><Reference><Citation>Yengo L, Sidorenko J, Kemper KE, et al. Meta‐analysis of genome‐wide association studies for height and body mass index in ∼700000 individuals of European ancestry. Hum Mol Gen. 2018;27(20):3641‐3649.</Citation></Reference><Reference><Citation>COVID‐19 Host Genetics Initiative. The COVID‐19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS‐CoV‐2 virus pandemic. Eur J Human Genet. 2020;28(6):715‐718.</Citation></Reference><Reference><Citation>Bellizzi ColeTJ, Flegal MC, Dietz KM. WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320(7244):1240‐1243.</Citation></Reference><Reference><Citation>Bradfield JP, Vogelezang S, Felix JF, et al. A trans‐ancestral meta‐analysis of genome‐wide association studies reveals loci associated with childhood obesity. Hum Mol Gen. 2019;28(19):3327‐3338.</Citation></Reference><Reference><Citation>Niemi MEK, Karjalainen J, Liao RG, et al Mapping the human genetic architecture of COVID‐19. Nature. 2021;600(7889):472‐477.</Citation></Reference><Reference><Citation>Sanderson E, Glymour MM, Holmes MV, et al. Mendelian randomization. Nature Reviews Methods Primers. 2022;2(1):6.</Citation></Reference><Reference><Citation>Hemani G, Zheng J, Elsworth B, et al. The MR‐Base platform supports systematic causal inference across the human phenome. eLife. 2018;e34408.</Citation></Reference><Reference><Citation>Bulik‐Sullivan BK, Loh P‐R, Finucane HK, et al. LD score regression distinguishes confounding from polygenicity in genome‐wide association studies. Nature Genet. 2015;47(3):291‐295.</Citation></Reference><Reference><Citation>Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan NA, Thompson JR. Assessing the suitability of summary data for two‐sample Mendelian randomization analyses using MR‐Egger regression: the role of the I2 statistic. Int J Epidemiol. 2016;45(6):1961‐1974. doi:10.1093/ije/dyw220</Citation></Reference><Reference><Citation>Burgess S, Thompson SG. Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol. 2015;181(4):251‐260.</Citation></Reference><Reference><Citation>Brion MJA, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 2013;42(5):1497‐1501.</Citation></Reference><Reference><Citation>Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304‐314.</Citation></Reference><Reference><Citation>Zhao Q, Wang J, Hemani G, Bowden J, Small DS. Statistical inference in two‐sample summary‐data Mendelian randomization using robust adjusted profile score. The Annals of Statistics. 2020;48(3):1742‐1769.</Citation></Reference><Reference><Citation>Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512‐525.</Citation></Reference><Reference><Citation>Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nature Genet. 2018;50(5):693‐698.</Citation></Reference><Reference><Citation>Bowden J, Spiller W, Del Greco M F, et al. Improving the visualization, interpretation and analysis of two‐sample summary data Mendelian randomization via the radial plot and radial regression. Int J Epidemiol. 2018;47(4):1264‐1278.</Citation></Reference><Reference><Citation>Mounier N, Kutalik Z. Bias correction for inverse variance weighting Mendelian randomization. Genet Epidemiol. 2023;47(4):314‐331.</Citation></Reference><Reference><Citation>Grant AJ, Burgess S. Pleiotropy robust methods for multivariable Mendelian randomization. Stat Med. 2021;40(26):5813‐5830.</Citation></Reference><Reference><Citation>Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID‐19‐related death using OpenSAFELY. Nature. 2020;584(7821):430‐436.</Citation></Reference><Reference><Citation>Jain V, Yuan J‐M. Predictive symptoms and comorbidities for severe COVID‐19 and intensive care unit admission: a systematic review and meta‐analysis. Int J Public Health. 2020;65(5):533‐546.</Citation></Reference><Reference><Citation>Swann OV, Holden KA, Turtle L, et al Clinical characteristics of children and young people admitted to hospital with covid‐19 in United Kingdom: prospective multicentre observational cohort study. BMJ. 2020;370:m3249. doi:10.1136/bmj.m3249</Citation></Reference><Reference><Citation>Docherty AB, Harrison EM, Green CA, et al Features of 20 133 UK patients in hospital with covid‐19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ. 2020;369:m1985. doi:10.1136/bmj.m1985</Citation></Reference><Reference><Citation>Maimunah U, Maharani AR, Soegiarto G, et al. Correlation between interleukin‐6 expression in post‐mortem core liver biopsy and degree of liver injury in patients with fatal COVID‐19. Narra J. 2023;3(3):e463.</Citation></Reference><Reference><Citation>Harapan H, Fajar JK, Supriono S, et al. The prevalence, predictors and outcomes of acute liver injury among patients with COVID‐19: a systematic review and meta‐analysis. Rev Med Virol. 2022;32(3):e2304.</Citation></Reference><Reference><Citation>Yoshiji S, Butler‐Laporte G, Lu T, et al. Proteome‐wide Mendelian randomization implicates nephronectin as an actionable mediator of the effect of obesity on COVID‐19 severity. Nature Metabolism. 2023;5(2):248‐264.</Citation></Reference><Reference><Citation>Juonala M, Magnussen CG, Berenson GS, et al. Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med. 2011;365(20):1876‐1885.</Citation></Reference><Reference><Citation>Weihrauch‐Blüher S, Schwarz P, Klusmann J‐H. Childhood obesity: increased risk for cardiometabolic disease and cancer in adulthood. Metabolism. 2019;92:147‐152.</Citation></Reference><Reference><Citation>Yuan S, Ruan X, Sun Y, et al. Birth weight, childhood obesity, adulthood obesity and body composition, and gastrointestinal diseases: a Mendelian randomization study. Obesity. 2023;31(10):2603‐2614.</Citation></Reference><Reference><Citation>Yan SS, Xu Q, Han BX, et al. Mendelian randomization analysis identified causal association of childhood obesity with adult major depressive disorder. Pediatric Obesity. 2022;17(12):e12960. doi:10.1111/ijpo.12960</Citation></Reference><Reference><Citation>Locasale JW, O'Nunain K, Park C, et al. A lifecourse mendelian randomization study highlights the long‐term influence of childhood body size on later life heart structure. PLoS Biol. 2022;20(6):e3001656. doi:10.1371/journal.pbio.3001656</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>